Cartesian Therapeutics Inc (RNAC) returns
Cartesian Therapeutics returns over 10 years
$1,000 invested in Cartesian Therapeutics ten years ago was worth $13.04 at the close on October 30, 2026, with dividends reinvested: an average return of -35.2% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -10.0% | — | $900.14 | -0.9% |
| 3 months | -16.0% | — | $839.59 | +2.1% |
| Year to date | -10.0% | — | $900.14 | +11.7% |
| 1 year | -20.0% | — | $800.25 | +12.4% |
| 3 years | -82.8% | -44.4% | $171.69 | +88.5% |
| 5 years | -94.0% | -43.0% | $60.26 | +76.0% |
| 10 years | -98.7% | -35.2% | $13.04 | +316.6% |
Cartesian Therapeutics return by calendar year
| Year | RNAC | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -10.0% | +11.7% | -21.7% |
| 2025 | -59.7% | +17.7% | -77.5% |
| 2024 | -13.4% | +24.9% | -38.3% |
| 2023 | -39.0% | +26.2% | -65.2% |
| 2022 | -65.3% | -18.2% | -47.2% |
| 2021 | +7.6% | +28.7% | -21.2% |
| 2020 | +27.3% | +18.4% | +8.9% |
| 2019 | -10.5% | +31.2% | -41.7% |
| 2018 | -72.9% | -4.6% | -68.3% |
| 2017 | -42.8% | +21.7% | -64.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also: RNAC financials
No forecast, no recommendation. This page describes Cartesian Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.